Altamira Therapeutics Ltd.: xbrl:AdjustedWeightedAverageShares

Value{"unit": "shares", "value": 45536}
Period2023-01-01 – 2023-12-31
Statussuperseded
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-24-034940
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/e4a65684-2a29-4199-9bd2-cde1d806a82f

History